RESEARCH BASE
Search 3,721 documents across 34 fields — every claim tier-rated by evidence
3,633 are the core, quality-scored corpus (34 lettered sections — see How We Work); the remaining 88 are cross-corpus synthesis documents (68 InterDocs, 12 Connections, 8 Theories) also indexed here.
102 results for "psychedelic pharmacology" — page 2 of 6
A_3_05 — Ancient Egyptian Medical and Scientific Papyri
Ancient Egyptian medical and scientific papyri constitute the earliest known systematic attempts at empirical investigation of the human body, disease, and the natural world. The Edwin Smith Papyrus (~1600 BCE, copied fr
X_5_01 — Venom, Toxicology, and Poison Medicine
Toxicology — the study of the adverse effects of chemical, physical, or biological agents on living organisms — and the medical management of poisoning and envenomation have ancient roots and a rich history intertwining
X_5_24 — Ancient Egyptian Medicine: The Edwin Smith Papyrus and Rational Healing
Ancient Egyptian medicine, documented in medical papyri spanning ~1900–1200 BCE but reflecting traditions potentially centuries older, represents one of the earliest systems to combine rational clinical observation with
X_1_07 — Indigenous Pharmacopeias: Validated Compounds
Indigenous peoples have developed sophisticated pharmacopeias over millennia of empirical observation and systematic experimentation — and modern pharmaceutical science has repeatedly validated these knowledge systems. A
X_4_15 — Addiction Medicine & Substance Abuse
Addiction medicine is a medical subspecialty formally recognised by the American Board of Medical Specialties (ABMS) in October 2015, though its intellectual roots stretch to Dr. Benjamin Rush's 1784 description of alcoh
ZF_5_14 — Marine Invertebrate Venoms: Cone Snails, Box Jellyfish, and Blue-Ringed Octopus
The oceans harbor an extraordinary diversity of venomous organisms — from the microscopic nematocysts (stinging cells) of cnidarians to the sophisticated venom injection systems of cone snails, blue-ringed octopuses, and
Z_2_18 — Pharmacogenomics and Precision Medicine
Pharmacogenomics — the study of how genetic variation affects individual responses to drugs — aims to replace the "one-size-fits-all" prescribing model with genotype-guided therapy, selecting the right drug at the right
Y_4_06 — Synesthesia and Cross-Modal Perception
Synesthesia — the involuntary, consistent experience of one sensory modality triggering perception in another (e.g., hearing colors, tasting shapes) — affects roughly 4% of the general population when broad subtype defin
Y_0_00 — Altered States & Psychedelics: Section Summary
Y_3_13 — Visionary Art: Depicting Altered States from Hildegard to Grey
Visionary art — artistic creation inspired by, depicting, or emerging from altered states of consciousness — spans the entire history of human image-making, from Paleolithic cave paintings (whose geometric patterns David
Y_1_03 — Classical Antiquity Entheogens Synthesis
This document examines Classical Antiquity Entheogens Synthesis, a topic within the Consciousness research area. Key areas of investigation include Were Ancient Mediterranean Religions Entheogenic?, Why This Matters, The
Y_1_11 — Ketamine: Dissociative Anesthetic and Consciousness Explorer
Ketamine is a dissociative anesthetic — first synthesized by Calvin Stevens in 1962 and introduced into clinical use by Edward Domino and Guenter Corssen (1966) — that has undergone a remarkable transformation from battl
Y_1_09 — Toxins, Venoms, and Altered States
Several animal toxins and plant poisons produce dramatic altered states of consciousness, and their use in ritual, medicine, and folklore constitutes a significant chapter in the relationship between humans and psychoact
Y_1_14 — Toad Venom: Bufo alvarius, 5-MeO-DMT, and Desert Sacrament
Toad venom — specifically the venom of the Sonoran Desert toad (Incilius alvarius, formerly Bufo alvarius) — contains 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT), one of the most potent psychoactive tryptamines known, p
Y_1_18 — Addiction Neurochemistry: Reward Circuits, Tolerance & Therapeutic Frontiers
Addiction — now formally termed substance use disorder (SUD, DSM-5) — is a chronic, relapsing brain disorder characterized by compulsive drug seeking despite harmful consequences, affecting approximately 35 million peopl
Y_1_10 — Ibogaine: African Plant Medicine and Addiction Interruption
Ibogaine is a naturally occurring psychoactive indole alkaloid derived from the root bark of the West African shrub Tabernanthe iboga, which has been used for centuries in the Bwiti spiritual tradition of Gabon, Cameroon
Y_1_00 — Psychedelics Entheogens: Subfolder Summary
X_5_22 — Paracelsus & the Birth of Chemical Medicine
Philippus Aureolus Theophrastus Bombastus von Hohenheim (1493–1541), self-named Paracelsus, was a Swiss-German physician-alchemist who revolutionized European medicine by rejecting Galenic humoral theory and introducing
X_5_19 — Drug Discovery: From Ethnobotany to Rational Design
Drug discovery is the process by which new therapeutic compounds are identified, developed, and brought to clinical use. The field has evolved through three major paradigms: (1) ethnobotanical/traditional knowledge — mos
X_4_05 — Mental Health and Psychiatry History
The history of mental health and psychiatry is a narrative of shifting paradigms — from spiritual possession to humoral imbalance, from moral failure to medical disease, and increasingly from biomedical reductionism towa
BROWSE BY SECTION — 3,721 documents across 34 fields